|
ID
|
Section
|
Field Name
|
Compulsory
|
Matching WHO ICTRP
fields #
|
|
1
|
APPLICANT
|
Applicant title
|
Yes
|
Not Applicable
|
|
2
|
APPLICANT
|
Applicant forename
|
Yes
|
Not Applicable
|
|
3
|
APPLICANT
|
Applicant surname
|
Yes
|
Not Applicable
|
|
4
|
APPLICANT
|
Applicant address
|
Yes
|
Not Applicable
|
|
5
|
APPLICANT
|
Applicant town
|
Yes
|
Not Applicable
|
|
6
|
APPLICANT
|
Applicant country
|
Yes
|
Not Applicable
|
|
7
|
APPLICANT
|
Applicant zip
|
Yes
|
Not Applicable
|
|
8
|
APPLICANT
|
Applicant tel
|
No
|
Not Applicable
|
|
9
|
APPLICANT
|
Applicant fax
|
No
|
Not Applicable
|
|
10
|
APPLICANT
|
Applicant email
|
Yes
|
Not Applicable
|
|
11
|
APPLICANT
|
Where did you hear about the ISRCTN scheme?
|
No
|
Not Applicable
|
|
12
|
CONTACT
|
Contact (LPI) title
|
Yes
|
7 & 8
|
|
13
|
CONTACT
|
Contact forename
|
Yes
|
7 & 8
|
|
14
|
CONTACT
|
Contact surname
|
Yes
|
7 & 8
|
|
15
|
CONTACT
|
Contact address
|
Yes
|
7 & 8
|
|
16
|
CONTACT
|
Contact city
|
Yes
|
7 & 8
|
|
17
|
CONTACT
|
Contact country
|
Yes
|
7 & 8
|
|
18
|
CONTACT
|
Contact zip
|
Yes
|
7 & 8
|
|
19
|
CONTACT
|
Contact tel
|
No
|
7 & 8
|
|
20
|
CONTACT
|
Contact fax
|
No
|
7 & 8
|
|
21
|
CONTACT
|
Contact email
|
Yes
|
7 & 8
|
|
22
|
CONTACT
|
Contact privacy
|
Yes
|
7 & 8
|
|
23
|
SPONSOR
|
Sponsor name
|
Yes
|
5 & 6
|
|
24
|
SPONSOR
|
Sponsor address
|
Yes
|
5 & 6
|
|
25
|
SPONSOR
|
Sponsor town
|
Yes
|
5 & 6
|
|
26
|
SPONSOR
|
Sponsor country
|
Yes
|
5 & 6
|
|
27
|
SPONSOR
|
Sponsor zip
|
Yes
|
5 & 6
|
|
28
|
SPONSOR
|
Sponsor tel
|
No
|
5 & 6
|
|
29
|
SPONSOR
|
Sponsor fax
|
No
|
5 & 6
|
|
30
|
SPONSOR
|
Sponsor email
|
Yes
|
5 & 6
|
|
31
|
SPONSOR
|
Sponsor website
|
No
|
5 & 6
|
|
32
|
SPONSOR
|
Sponsor privacy
|
Yes
|
5 & 6
|
|
33
|
TRIAL
|
ClinicalTrials.gov identifier
(IF THERE IS ONE)
|
No
|
1
|
|
34
|
TRIAL
|
Protocol/serial number
|
Yes
|
3
|
|
35
|
TRIAL
|
Public title
|
Yes
|
9
|
|
36
|
TRIAL
|
Scientific title
|
No
|
10
|
|
37
|
TRIAL
|
Acronym
|
Yes
|
3
|
|
38
|
TRIAL
|
Disease/condition/study domain
|
Yes
|
12
|
|
39
|
TRIAL
|
Study hypothesis
|
Yes
|
15
|
|
40
|
TRIAL
|
Ethics approval
|
Yes
|
Not Required
|
|
41
|
TRIAL
|
Study design
|
Yes
|
15
|
|
42
|
TRIAL
|
Countries of recruitment
|
Yes
|
11
|
|
43
|
TRIAL
|
Participants - inclusion criteria
|
Yes
|
14
|
|
44
|
TRIAL
|
Participants - exclusion criteria
|
Yes
|
14
|
|
45
|
TRIAL
|
Patient information material
|
No
|
Not Required
|
|
46
|
TRIAL
|
Anticipated start date
|
Yes
|
16
|
|
47
|
TRIAL
|
Anticipated end date
|
Yes
|
16
|
|
48
|
TRIAL
|
Target number of participants
|
Yes
|
17
|
|
49
|
TRIAL
|
Status
|
Yes
|
18
|
|
50
|
TRIAL
|
Interventions
|
Yes
|
13
|
|
51
|
TRIAL
|
Primary outcome measures(s)
|
Yes
|
19
|
|
52
|
TRIAL
|
Secondary outcome measures(s)
|
Yes
|
20
|
|
53
|
TRIAL
|
Trial website
|
No
|
Not Required
|
|
54
|
TRIAL
|
Publications
|
No
|
Not Required
|
|
55
|
TRIAL
|
Sources of funding (& refs)
|
Yes
|
4
|
|
56
|
TRIAL
|
ISRCTN
|
Generated
|
1
|
|
57
|
TRIAL
|
Date applied
|
Generated
|
Not Applicable
|
|
58
|
TRIAL
|
Date ISRCTN assigned
|
Generated
|
2
|